Median returns three months post IPO 2024 performance (the green line in Chart 5) were much better than the last two years (purple and pink lines). Importantly, 2024 IPOs as a group have so far held ...

Polish medical diagnostics company Diagnostyka on Friday said it priced its initial public offer at 105 zlotys per share, the ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

With a 25% share of the organized eye care market and a proven track record, Dr. Agarwal's Health Care IPO marks a significant moment for the specialized healthcare sector. However, a high premium may ...

Chart 1: U.S. leads global IPO activity in 2024, followed by Asian markets Since most countries have very different sized economies and stock markets, it’s a little unfair to compare countries ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.

Do you ever wish you could go back in time and invest in a company that got big? Some companies, which seemed like nothing back in the day, are now worth millions and sometimes billions. One of ...

Dr Agarwals' Health Care shares debuted on BSE today at a 1.27% discount, listing at Rs 396.90 per share against the IPO ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bar chart depicting major energy New York IPOs by ... according to the Venture Global's IPO filing. Chief Executive Officer Sabel received a total of $70 million for 2023 and 2024 while Executive ...